By expenditures
| Name | Title | Type |
|---|---|---|
| Paul Garcia | Partner | Auditee |
| Stephanie Gonzales | DIRECTOR OF BUDGET & FINANANCE/COMPTROLL | Auditee |
| Alan D. Bowers, Jr. | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 346437 | 2024 | 2025-03-17 | Carr Riggs & Ingram | $24.72M |
| 16132 | 2023 | 2024-02-07 | Carr Riggs & Ingram LLC | $31.43M |
| 46719 | 2022 | 2023-02-10 | Carr Riggs & Ingram LLC | $22.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 346437 | 2024 | 2025-03-17 | 1104880 | 2024-006 | Significant Deficiency | - | AB |
| 346437 | 2024 | 2025-03-17 | 1104879 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104878 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104877 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104876 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104875 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104874 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104873 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104872 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104871 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104870 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104869 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104868 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104867 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104866 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104865 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104864 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104863 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104862 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104861 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104860 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104859 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104858 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104857 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104856 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104855 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104854 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104853 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104852 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104851 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104850 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104849 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104848 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104847 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104846 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104845 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104844 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104843 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104842 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104841 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104840 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104839 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104838 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104837 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104836 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104835 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104834 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104833 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104832 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104831 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104830 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104829 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104828 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104827 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104826 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104825 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104824 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104823 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104822 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104821 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104820 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104819 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104818 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104817 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104816 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104815 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104814 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104813 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104812 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104811 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104810 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104809 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 1104808 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 1104807 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528438 | 2024-006 | Significant Deficiency | - | AB |
| 346437 | 2024 | 2025-03-17 | 528437 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528436 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528435 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528434 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528433 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528432 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528431 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528430 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528429 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528428 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528427 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528426 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528425 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528424 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528423 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528422 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528421 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528420 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528419 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528418 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528417 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528416 | 2024-003 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528415 | 2024-005 | Significant Deficiency | Yes | I |
| 346437 | 2024 | 2025-03-17 | 528414 | 2024-004 | Material Weakness | - | ABH |
| 346437 | 2024 | 2025-03-17 | 528413 | 2024-003 | Material Weakness | - | ABH |